← Signals · Healthcare · TSXV
$NPTH
Neupath Health Inc.
Signal as of N/A  ·  90-day rolling window  ·  Healthcare Providers & Services
Confluence Score
—
out of 100  ·  Full breakdown →
Score delayed 7 days on Free  ·  See today's score — Analyst →
Signals scoring 20–39 have historically hit 47% of the time (avg +6.8% over 90 days, 105 backtested signals). Methodology →
🔒 Risk monitoring — insider-selling & reversal warnings (Analyst)
7 open-market buys  ·  6 unique buyers  ·  $474K total Lobbying: 0 regs  ·  Contracts: 0 wins
Confluence Score
—
Unlock breakdown →
Insider Activity (90d)
7
6 buyers  ·  $474K  ·  open-market only
Current Price
$0.66
CAD  ·  5-min cache
Market Cap
$38M
CAD  ·  TMX
Lobbying & Contracts
None
0 regs  ·  0 contracts
Healthcare on Form55: 43% hit rate · -5.4% alpha vs XIU.TO · 21 closed signals Track Record →
★
Signal Analyst
The Confluence Score and insider trade feed above are free. Signal Analyst adds the full component breakdown, lobbying registrations, and contract wins — plus alerts when this company's signal moves, so you don't have to keep checking back.
Monitor — CAD $29/mo
Price Chart
12 months daily  ·  TSXV:NPTH
Insider Transactions
90-day window  ·  17 filings
Date Insider Role Nature Dir. Shares Buy Price Return Value
Jun 30, 2026 NeuPath Health Inc. — Buyback Buy 60,000 — — —
Jun 15, 2026 Chicoine, Daniel — Corp. Event Sell 20,000 — — —
Jun 15, 2026 Chicoine, Daniel — Corp. Event Buy 20,000 $0.63 +4.8%  · 24d $13K
Jun 15, 2026 Cucuz, Sasha — Corp. Event Sell 20,000 — — —
Jun 15, 2026 Cucuz, Sasha — Corp. Event Buy 20,000 $0.63 +4.8%  · 24d $13K
Jun 15, 2026 Legault, Daniel Marcel — Corp. Event Sell 20,000 — — —
Jun 15, 2026 Legault, Daniel Marcel — Corp. Event Buy 20,000 $0.63 +4.8%  · 24d $13K
Jun 11, 2026 NeuPath Health Inc. — Buyback Buy 5,000 $0.63 +4.8%  · 28d $3K
Jun 11, 2026 Chicoine, Daniel — Plan / DRIP Buy 50,000 — — —
Jun 11, 2026 Cucuz, Sasha — Plan / DRIP Buy 50,000 — — —
Jun 11, 2026 Legault, Daniel Marcel — Plan / DRIP Buy 50,000 — — —
Jun 11, 2026 Walewicz, Joseph Andrew — Plan / DRIP Buy 50,000 — — —
Jun 11, 2026 Zygouras, Zaffirios — Other Buy 382,978 $0.47 +40.4%  · 28d $180K
Jun 11, 2026 Walewicz, Joseph Andrew — Other Buy 510,638 $0.47 +40.4%  · 28d $240K
Jun 09, 2026 NeuPath Health Inc. — Buyback Buy 7,500 $0.56 +17.9%  · 30d $4K
Jun 08, 2026 NeuPath Health Inc. — Buyback Buy 7,500 $0.57 +15.8%  · 31d $4K
Jun 05, 2026 NeuPath Health Inc. — Buyback Buy 7,500 $0.58 +13.8%  · 34d $4K
Score uses open-market buys only  ·  0 open-market  ·  14 plan / compensation shown but not scored  ·  Return is unrealized, to today's price; a “· Nd” mark means the 90-day window is still open (N of 90 days) — too early to judge.
Score Breakdown
Signal Analyst  ·  $29/mo
Component Points Max Detail Weight
Conviction (unique buyers)  ✓ FREE PREVIEW 15 30 6 unique buyers
Buy/sell ratio 20 70% buys (7B / 3S)
Dollar value 25 $474K
Lobbying activity 15 None
Contract wins 10 None
Insider track record 10 No track record data
Private placements 8 None
Confluence bonus 10 None
Cluster timing (velocity) 10 No coordinated buying cluster detected
Buy/sell reversal pattern 8 No buy/sell reversal pattern
Total 0 100
Unlock Component Detail — CAD $29/mo
Lobbying Registrations
OCL active  ·  none found
No active OCL lobbying registrations in the last 90 days. Analyst plan →
Government Contract Wins
90-day window  ·  none found
No government contract wins in the last 90 days. Analyst plan →
Private Placements
12 months  ·  Signal Analyst  ·  $29/mo
Private placement history, deal size, and lock-up expiry tracking. Analyst plan →
Indigenous Consultation
no records on file

No Indigenous consultation records on file for NPTH.

SEDAR+ Filings
official filing registry
Form55 monitors SEDAR+ filing alerts and newswire announcements for Technical Reports and material changes. Search SEDAR+ →
Short Interest
CIRO  ·  Jun 30, 2026
Shares short
6,327
Net change
-14,923 (-70.2%)
History
Jun 30: 6,327
Jun 15: 21,250
May 31: 20,631
May 15: 85,256
Apr 30: 59,338
Apr 15: 41,544
Aggregate short position from CIRO's Consolidated Short Position Report (published twice monthly).
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.